Mesenteric Panniculitis: Causes and Treatment
Mesenteric panniculitis is a benign, idiopathic chronic inflammatory condition of the mesenteric adipose tissue that is most commonly asymptomatic and discovered incidentally on CT imaging, requiring treatment only when symptomatic with first-line therapy being prednisone and tamoxifen.
Etiology and Pathophysiology
The exact cause of mesenteric panniculitis remains largely unknown and speculative 1, 2, 3. The condition represents a spectrum of disease characterized by:
- Chronic nonspecific inflammation of mesenteric adipose tissue
- Fat necrosis with progressive fibrosis and scarring
- Predominantly affects the small bowel mesentery 4, 2, 5
Proposed Associations (Not Proven Causation)
While several associations have been suggested in the literature, recent case-control studies indicate mesenteric panniculitis is likely an independent, non-specific, benign age-related phenomenon rather than a paraneoplastic condition 4. Historical associations that remain unproven include:
- Prior abdominal surgery or trauma 1
- Inflammatory diseases 1
- Possible association with malignant lymphoma (debated) 6, 4
- Inflammatory bowel disease (rare, poorly characterized) 7
Critical caveat: The association with malignancy, particularly lymphoma, remains scientifically debated with conflicting evidence 6, 4.
Clinical Presentation
Symptom Profile
- Asymptomatic in up to 50% of cases - most commonly an incidental CT finding 4, 3, 5
- When symptomatic, presents with:
Demographics
- Predominantly affects men in mid to late adulthood 4
- True prevalence likely higher than reported 0.6-2.4% due to underreporting 4
Diagnosis
Imaging - CT with IV Contrast (Diagnostic Standard)
Characteristic CT findings include 5:
- Mass-like area of increased fat attenuation within small bowel mesentery
- Typically located in left upper quadrant
- "Misty mesentery" appearance 1
- Envelops mesenteric vessels without obstruction
- Displaces adjacent bowel segments
- Lymph nodes frequently present within abnormal mesenteric area
When to Obtain Tissue Biopsy
Histological confirmation is not routinely required but should be obtained when 1, 3:
- Diagnosis remains unclear on imaging
- Malignancy (particularly lymphoma) cannot be excluded
- Severe presentation with mass effect, bowel obstruction, or ischemic changes
Role of PET/CT
Consider PET/CT if there is suspicion of concurrent underlying malignancy, as lymphoma is the primary differential diagnosis 5.
Treatment Algorithm
Asymptomatic Patients
No treatment required - observation only 4, 3
Symptomatic Patients Without Complications
First-line medical therapy 8, 5:
Prednisone (primary agent)
- Patients on prednisone showed good clinical and radiological responses during follow-up 8
Tamoxifen (often combined with prednisone)
Alternative agents (when first-line fails or as adjuncts) 8:
- Azathioprine
- Colchicine
- NSAIDs 3
Patients with Complications
- Recurrent bowel obstruction
- Mass effect causing significant symptoms
- Ischemic changes
- Diagnostic uncertainty requiring tissue confirmation
- Failure of medical therapy 8
Management Pitfalls to Avoid
Do not assume malignancy: While lymphoma is the main differential, mesenteric panniculitis is benign in nature - avoid overtreatment 4, 5
Do not treat asymptomatic cases: The majority of patients require no intervention 4, 3
Do not perform routine biopsies: CT findings are usually diagnostic; reserve biopsy for equivocal cases 8, 3
Do not assume paraneoplastic relationship: Despite historical teaching, recent evidence suggests mesenteric panniculitis is an independent age-related phenomenon 4
Exclude malignancy systematically: Given the overlap in imaging appearance with lymphoma, ensure thorough evaluation before committing to conservative management 1, 5
Follow-Up Considerations
For patients treated medically, monitor both clinical symptoms and radiological findings during follow-up to assess treatment response 8. The condition is benign but requires careful monitoring to prevent complications 1.